A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines
<p>Abstract</p> <p>Background</p> <p>In 2001, two hexavalent vaccines were licensed in Italy (Hexavac<sup>®</sup>, Infanrix Hexa<sup>®</sup>), and since 2002 were extensively used for primary immunization in the first year of life (at 3, 5, 11/12 months of age). In 2005, the market authorization of...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2008-07-01
|
| Colección: | BMC Infectious Diseases |
| Acceso en línea: | http://www.biomedcentral.com/1471-2334/8/100 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|